ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $519K of Zentalis Pharmaceuticals, Inc.
Sold$519,295
$51.93Price
10,000Shares
−3%Stake
What ZNTL did after the filing
- The stock from Tue, Feb 15 close, $52.68
- −13.5%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the Mar 30 close.
Traded Tue, Feb 15. Filed Tue, Feb 15, 1:35 PM ET, during the session. Returns use the Feb 15 close and the Mar 30 close. Not investment advice.